/Investor DB

Alta Life Sciences — Full Portfolio

8 tracked investments · listed companies and verified rows first

Accure Therapeuticsaccure.healthSeries A · May 2020 · $8M

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.

BiotechHealthtech

Laurent Nguyen(Chief Executive Officer, Board member)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in

Co-investorsAliath BioventuresAsabys PartnersKinled HoldingLifelink

Clear Labsclearlabs.cominSeries B · Oct 2018 · $21M

Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.

BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US

Sasan Amini(Founder)inRamin Khaksar(Founder)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)

Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+14 more

Deepulldeepull.cominSeries A · Jul 2020 · $4M

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsAsabys PartnersColumbus Venture PartnersKurma PartnersPanakes Partners

Inbiomotioninbiomotion.comJan 2021

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.

BiotechDigital HealthMedical Devices

BoardProf Rob E. Coleman(Chairman)

Co-investorsAsabys PartnersCriteria Bio VenturesYsios Capital

Mediktormediktor.cominOct 2021 · $13M

Mediktor is an AI-powered healthcare chatbot platform that enables patients to assess symptoms and receive preliminary guidance through natural language conversations.

AI & Machine LearningDigital HealthHealthtechBarcelona, ES

Oscar García-Esquirol(Co-founder / Medical Director)inCristian Pascual(Founder)inRoger Forcada(CTO)in

Co-investorsAsabys Partners

Onaona.comin𝕏Jun 2020

Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.

AI & Machine LearningCloud ComputingDeveloper Tools

Jan Koehnlein(Founder)Johannes Landgraf(Founder)Moritz Eysholdt(Founder)Sven Efftinge(Founder)

Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesVertex VenturesAsabys Partners+7 more

Ona Therapeuticsona-therapeutics.comin𝕏Series A · Jun 2020 · $34M

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsAsabys PartnersFund+KorysMérieux Equity PartnersYsios CapitalBpifrance+2 more

Peptomycpeptomyc.comin𝕏

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))in

Co-investorsAsabys PartnersAurora ScienceInvivo Capital Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.